等待开盘 07-02 09:30:00 美东时间
-0.200
-0.96%
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
BTIG analyst Vincent Caintic maintains Happen (NASDAQ:HAPN) with a Buy and raises the price target from $20 to $25.
06-30 18:10
Begins trading on Nasdaq under the ticker symbol "HAPN" SAN FRANCISCO, June 22, 2026 /PRNewswire/ -- Happen, Inc. (Nasdaq: HAPN) https://www.multivu.com/lending-club/9384851-en-lendingclub-b...
06-22 21:05